Skip to content

Radiotherapy for pathological stage Ia and IIa (Upper) Hodgkin's disease

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN98387311
Enrollment
Unknown
Registered
2001-07-01
Start date
1998-01-01
Completion date
Unknown
Last updated
2015-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lymphoma (Hodgkin's) Cancer Lymphoma (Hodgkin's)

Interventions

This is a non randomised study, patients are grouped according to site and stage of disease: 1. Group A: Patients with pathological stage Ia (neck), IIa (neck) and Ia (axilla) are assigned to local f

Sponsors

Cancer Research UK (CRUK) (UK)
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Pathological stage Ia and IIa (upper) Hodgkin's disease 2. Aged 15 to 65 years

Exclusion criteria

Exclusion criteria: Patients with mediastinal disease will not in general be eligible for local radiotherapy alone

Design outcomes

Primary

MeasureTime frame
Not provided at time of registration

Secondary

MeasureTime frame
Not provided at time of registration

Countries

United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026